Biological and clinical perspectives of TERT promoter mutation detection on bladder cancer diagnosis and management.

导出 LinkOut

翻译打印收藏纠错

第一作者： Liang,Cheng

第一单位： Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN, 46202, USA; Department of Pathology and Laboratory Medicine, Warren Alpert Medical School of Brown University and Lifespan Academic Medical Center, Providence, RI, 02903, USA. Electronic address: liang_cheng@yahoo.com.

作者： Liang,Cheng ^[1] ; Shaobo,Zhang ^[2] ; Mingsheng,Wang ^[2] ; Antonio,Lopez-Beltran ^[3]

作者单位： Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN, 46202, USA; Department of Pathology and Laboratory Medicine, Warren Alpert Medical School of Brown University and Lifespan Academic Medical Center, Providence, RI, 02903, USA. Electronic address: liang_cheng@yahoo.com. ^[1] Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN, 46202, USA. ^[2] Department of Morphological Sciences, University of Cordoba Medical School, Cordoba, E-14004, Spain. ^[3]

关键词 Bladder cancer Differential diagnosis Early detection Molecular genetics Telomerase reverse transcriptase (TERT) promoter mutation Urothelial carcinoma

主题词人类(Humans);癌, 移行细胞(Carcinoma, Transitional Cell);突变(Mutation);启动区, 遗传(Promoter Regions, Genetic);末端转移酶端粒(Telomerase);膀胱(Urinary Bladder);膀胱肿瘤(Urinary Bladder Neoplasms)

DOI 10.1016/j.humpath.2022.06.005

PMID 35700749

发布时间 2023-03-30

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交